EP Patent

EP0835126B1 — Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders

Assigned to Eisai R&D Management Co Ltd · Expires 2003-04-02 · 23y expired

What this patent protects

Disclosed is the use of an omega-conopeptide in the manufacture of a medicament for inhibiting progression of neuropathic pain disorders.

USPTO Abstract

Disclosed is the use of an omega-conopeptide in the manufacture of a medicament for inhibiting progression of neuropathic pain disorders.

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: EP0835126B1
Jurisdiction: EP
Classification: —
Expires: 2003-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Eisai R&D Management Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.